Anzeige
Mehr »
Login
Samstag, 19.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Diese Aktie steigt um 225%! Ist ein Kupfer-Engpass im Gange?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
420 Leser
Artikel bewerten:
(1)

Chatham Imports and Mestre Consortium Form 50/50 Venture for Super Premium Mezcal Los Siete Misterios

MEXICO CITY and NEW YORK, March 25, 2021 /PRNewswire/ -- Chatham Imports, a global supplier of premium spirits and wine brands and the parent company of Michter's Distillery, and a consortium led by Eduardo and Julio Mestre have formed a new 50/50 venture to own the global trademark rights to the celebrated super-premium mezcal Los Siete Misterios.

Under the agreement, Chatham becomes the exclusive global sales and marketing agent for Los Siete Misterios, excluding Mexico, while the Mestres remain responsible for the production of Los Siete Misterios as well as sales in Mexico. This new partnership, which entails an equity investment by Chatham, will bolster Los Siete Misterios' production capacity and enhance the brand's route-to-market within the United States and abroad.

Julio Mestre, CEO of Los Siete Misterios, commented: "We have known Matt Magliocco and his family for years and we have been following what they have achieved with Michter's internationally and the great job they have done. We couldn't think of a better partner to help us take Los Siete Misterios to the next level. Both companies have the same values and each of us shares the same passion to produce the best spirits in our respective categories. That's why we are certain this will be a great venture for both companies."

Matt Magliocco, Executive Vice President of Chatham, commented: "We are absolutely thrilled to partner with Julio and Eduardo in the development of Los Siete Misterios. I have been friends with Julio and Eduardo for years, and from the very first day we met, I have admired their commitment to producing superb Oaxaca mezcal ethically and responsibly. Since founding Los Siete Misterios in 2010, Julio, Eduardo, and their team have done a remarkable job establishing one of the world's greatest mezcals and have earned a well-deserved reputation as leaders in our industry."

Magliocco added, "Los Siete Misterios delivers in every respect, from the consistently delicious liquid across its diverse range of expressions to the arresting Catrinas artwork. The brand's preeminent status in Mexico City's renowned bars and restaurants is a testament to Los Siete Misterios' reputation and credibility at home. For Chatham, Los Siete Misterios exemplifies all the qualities we value in a brand and aligns perfectly with our existing portfolio. We cannot wait to bring Los Siete Misterios to more people in the United States and around the world."

About Los Siete Misterios

Founded in 2010 by Julio and Eduardo Mestre with only one thing in mind: to respect and preserve the mezcal making traditions, as well as to promote local commerce and stimulate the culture of small mezcal producers, all of this with a contemporary approach. Thus, we were able to relive the past and match it with the present time, combining the best of both worlds. We remain respectful of one of the purest essences: the mezcal, a genuine Mexican heritage. The legends and mysteries of Mexico, our land, were our source of inspiration to start a quest, looking for a beverage that is fully representative of the Mexican customs, culture and of course the passion that goes along with every Mexican product. With support from our bartender friends in over 20 countries, we have established Los Siete Misterios as one of the most beloved brands in the Mezcal category. Los Siete Misterios offers a wide range of mezcals starting with Doba Yej, a copper pot-distilled Espadín; our Ancestral line of clay pot-distilled Espadín, Barril, Mexicano, Coyote, Arroqueño and Tobalá; our new Ensamble collection of copper pot-distilled Espadín and wild agave blends; and special releases including our Pechuga expression. For more information, please visit www.sietemisterios.com

About Chatham Imports

Headquartered in Manhattan's Flatiron District, Chatham represents a portfolio of quality-focused spirits, wine, and beer labels.Chatham's spirits brands include Michter's American Whiskey and its Legacy Series consisting of Bomberger's Declaration Bourbon and Shenk's Homestead Sour Mash, Crop Harvest Earth Organic Vodka, Farmer's Organic Gin, Foro Amaro and Vermouth, Martí Autentico Rum, and Faretti Biscotti Liqueur.Chatham's wine offerings are led by Santa Marina and Tuffo, while the portfolio is rounded out with New Amsterdam Beer.Chatham's subsidiaries include Michter's Shively and Fort Nelson distilleries in Louisville, Kentucky, as well as Michter's 145-acre farm and operations in Springfield, Kentucky.Chatham products are sold in all 50 United States as well as approximately 60 foreign markets spanning the Americas, Europe, the Middle East, and Asia-Pacific. For more information, please visit www.chathamimports.com.

Chatham Imports Contact:

Los Siete Misterios Contact:

Matt Magliocco

Eduardo Mestre

+1 (502) 774-2300 x470

+52 55 29812311

mmagliocco@chathamimports.com

emestre@sietemisterios.com

Eduardo (left) and Julio (right) Mestre

Logo - https://mma.prnewswire.com/media/1473526/Chatham_Imports_Logo.jpg
Photo - https://mma.prnewswire.com/media/1473527/Los_Siete_Misterios_Mezcal.jpg
Photo - https://mma.prnewswire.com/media/1473528/Julio_and_Eduardo_Mestre.jpg

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.